Do Natural Anticoagulant Deficiencies Worsen Ischaemic Stroke Severity?
Sodiq Lawal, Peer Reviewer Interventional Neuroradiology at Sage, shared on LinkedIn:
“Could deficiencies in natural anticoagulants influence how severe an ischaemic stroke becomes, especially in under-studied African populations?
I’m pleased to share our newly published study examining Protein C and Protein S levels in Nigerian adults with acute ischaemic stroke and how they relate to stroke severity and functional outcomes.
Key findings:
- Protein C levels were significantly lower in patients with ischaemic stroke compared with healthy controls
- Lower Protein C showed a weak but significant correlation with stroke severity
- Protein S levels showed no significant difference
- Neither protein was associated with short-term functional outcomes
Why this matters:
Our findings suggest that Protein C deficiency may reflect stroke severity rather than recovery, raising important questions about its pathophysiological role and potential utility as a biomarker in low-resource settings, where stroke burden is rising rapidly.
Read the paper here:

I’d really value perspectives from clinicians and researchers:
Do you see a role for thrombophilia markers like Protein C in stroke risk stratification or research, particularly in LMICs?”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A